Harmonization of immunotoxicity guidelines in the ICH process - Pathology considerations from the Guideline Committee of the European Society of Toxicological Pathology (ESTP)

Experimental and Toxicologic Pathology

Volumn 57, Issue 1, 2005, Pages 1-5

  Ruehl Fehlert, Christine ^a   Bradley, Alys ^b   George, Catherine ^c   Germann, Paul Georg ^d   Bolliger, Anne Provencher ^d   Schulte, Agnes ^e  

^a BAYER PHARMA AG   (Germany)

^b Inveresk Research   (United Kingdom)

^c PFIZER INC   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Guideline; Immunopathology; Immunotoxicology; Standardization; Technique

Indexed keywords

HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; IMMUNOTOXICITY; LYMPH NODE; LYMPHOID ORGAN; ORGAN SIZE; ORGANIZATION; PEYER PATCH; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; REVIEW; SAMPLING; SCIENCE; STANDARD; TECHNIQUE; TOXICITY TESTING;

EID: 21544460985     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2005.03.001     Document Type: Article

References (32)

1. D.A. Basketter, J.N. Bremmer, and P. Buckley Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology Food Chem Toxicol 33 1995 239 243
2. J.H. Dean A brief history of immunotoxicity and a review of the pharmaceutical guidelines Int J Toxicol 23 2004 83 90
3. J.H. Dean, J.R. Hincks, and B. Remandet Immunotoxicology assessment in the pharmaceutical industry Toxicol Lett 102-103 1998 247 255
4. J.H. Dean, M.I. Luster, and G.A. Boorman Procedures available to examine the immunotoxicity of chemicals and drugs Pharmacol Rev 34 1982 137 148
5. EMEA. Note for guidance on repeated dose toxicity (CPMP/SWP/1042/99), 2000.
6. D.R. Germolec, A. Nyska, and M. Kashon Extended histopathology in immunotoxicity testing: interlaboratory validation studies Toxicol Sci 78 2004 107 115
7. D.R. Germolec, M. Kashon, and A. Nyska The accuracy of extended histopathology to detect immunotoxic chemicals Toxicol Sci 82 2004 504 514
8. J.H. Harleman Approaches to the identification and recording of findings in the lymphoreticular organs indicative for immunotoxicity in regulatory type toxicity studies Toxicology 142 2000 213 219
9. K.L. Hastings Implications of the new FDA/CDER immunotoxicity guidance for drugs Int Immunopharmacol 2 2002 1613 1618
10. D.M. Hinton US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins Toxicol Pathol 28 2000 467 478
11. International Collaborative Immunotoxicity Study (ICICIS) Group Investigators. Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology 1998;124:183-201.
12. I. Kimber, and R.J. Dearman Immune responses: adverse versus non-adverse effects Toxicol Pathol 30 2002 54 58
13. C.F. Kuper, J.H. Harleman, and H.B. Richter-Reichhelm Histopathologic approaches to detect changes indicative of immunotoxicity Toxicol Pathol 28 2000 454 466
14. Kuper CF, de Heer E, van Loveren H, et al. Immune system. In: Haschek WM, Rousseaux CG, Wallig MA, editors. Handbook of toxicologic pathology, 2nd ed., vol 2. San Diego, New York, Boston:Academic Press; 2002. p. 585-647.
15. Ministry of Health, Labour and Welfare (MHLW), Japan Pharmaceutical Manufacturers Association (JPMA). Interim draft guidance for immune toxicity testing, 2001.
16. Mohr U, editor. International classification of rodent tumours. Part I: The rat. 4. Haematopoietic system. IARC Scientific Publications No. 122. Lyon, France: International Agency for Research on Cancer; 1993.
17. G. Morawietz, C. Ruehl-Fehlert, and B. Kittel Revised guides for organ sampling and trimming in rats and mice - Part 3 Exp Toxic Pathol 55 2004 433 449
18. OECD: Guideline for the testing of chemicals 407. Repeated Dose 28-day oral toxicity study in rodents, 1995.
19. OECD: Guideline for the testing of chemicals 408. Subchronic oral toxicity study - rodent: 90-day study, 1981.
20. OECD: Guideline for the testing of chemicals 409. Subchronic oral toxicity non-rodent: 90-day study, 1981.
21. OECD: Guideline for the testing of chemicals 410. Repeated dose dermal toxicity: 21/28-day study, 1981.
22. OECD: Guideline for the testing of chemicals 411. Subchronic dermal toxicity: 90-day study, 1981.
23. OECD: Guideline for the testing of chemicals 412. Repeated dose inhalation toxicity: 28-day or 14-day study, 1981.
24. OECD: Guideline for the testing of chemicals 413. Subchronic inhalation toxicity: 90-day study, 1981.
25. H.-B. Richter-Reichhelm, C. Dasenbrock, and G. Descotes Validation of a modified 28-day rat study to evidence effects of test compounds on the immune system Regul Toxicol Pharmacol 22 1995 54 56
26. Richter-Reichhelm H-B, Schulte AE. Evaluation of the appropriateness of the extended subacute (28-day) toxicity test to detect adverse effects on the immune system. BgVV-Heft 04/1996, Berlin, 1996.
27. C. Ruehl-Fehlert, B. Kittel, and G. Morawietz Revised guides for organ sampling and trimming in rats and mice - Part 1 Exp Toxic Pathol 2-3 2003 91 106
28. A. Schulte, J. Althoff, and S. Ewe Two immunotoxicity ring studies according to OECD TG 407 - comparison of data on cyclosporin A and hexachlorobenzene Regul Toxicol Pharmacol 36 2002 12 21
29. Schulte A, Althoff J, Ewe S, et al. Screening for immunotoxic effects. Ring study with hexachlorobenzene based on the enhanced OECD test guideline 407. BgVV-Heft 07/2000, vols. I and II, Berlin, 2000.
30. US Food and Drug Administration, Department of Health and Human Services, Center for Drug Evaluation and Research (CDER). Guidance for industry immunotoxicology evaulation of investigational new drugs, 2002.
31. US Environmental Protection Agency. Health effects test guidelines OPPTS 870.7800 Immunotoxicity, 1998.
32. H-W. Vohr, and C. Ruehl-Fehlert Industry experience in the identification of the immunotoxic potential of agrochemicals Sci Total Environ 270 2001 123 133